TrialReach raises $13.5M for clinical trial-patient matching service

TrialReach raised $13.5 million in a Series B round to scale up its clinical trial discovery platform. The system is designed to accelerate enrollment into clinical research by matching patients to appropriate trials. London-based TrialReach takes a multipronged approach to the task, the first step of which is to convert jargon-heavy trial protocols into layman's terms. Smedvig Capital led the round. Release | More

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.